tm
Seeing Is Believing
tm
Seeing Is Believing
Jounce Therapeutics's activity chart (see below) currently has 29 price targets and 41 ratings on display.
Analysts average stock forecasts to be materialized ratio is 26.85% with an average time for these price targets to be met of 188.67 days.
Most recent stock forecast was given by from BAIRD on 28-Mar-2023.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 28-Mar-2023
$2
$0.12 (6.38%)
3 years 3 months 18 days ago
(28-Mar-2023)
0/2 (0%)
$0.16 (8.70%)
Buy Since 16-Mar-2022
$17
3 years 4 months 22 days ago
(24-Feb-2023)
0/1 (0%)
$9.68 (132.24%)
Buy Since 18-Sep-2021
3 years 4 months 23 days ago
(23-Feb-2023)
2/8 (25%)
$1.83 (156.41%)
622
Buy Since 23-May-2022
$5
$3.12 (165.96%)
3 years 6 months 13 days ago
(03-Jan-2023)
0/2 (0%)
$3.91 (358.72%)
Buy Since 26-Feb-2021
$11
$9.12 (485.11%)
$15
3 years 11 months 11 days ago
(05-Aug-2022)
0/2 (0%)
$6.84 (164.42%)
What is JNCE (Jounce Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on JNCE (Jounce Therapeutics) with a proven track record?
Which analyst has the most public recommendations on JNCE (Jounce Therapeutics)?
Which analyst is the currently most bullish on JNCE (Jounce Therapeutics)?
Which analyst is the currently most reserved on JNCE (Jounce Therapeutics)?
